References
- Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007;369:1641-57. https://doi.org/10.1016/S0140-6736(07)60751-X
- Rosen MJ, Dhawan A, Saeed SA. Inflammatory bowel disease in children and adolescents. JAMA Pediatr 2015;169:1053-60. https://doi.org/10.1001/jamapediatrics.2015.1982
- Sykora J, Pomahacova R, Kreslova M, Cvalinova D, Stych P, Schwarz J. Current global trends in the incidence of pediatric-onset inflammatory bowel disease. World J Gastroenterol 2018;24:2741-63. https://doi.org/10.3748/wjg.v24.i25.2741
- Ashton JJ, Cullen M, Afzal NA, Coelho T, Batra A, Beattie RM. Is the incidence of paediatric inflammatory bowel disease still increasing? Arch Dis Child 2018;103:1093-4. https://doi.org/10.1136/archdischild-2018-315038
- Ghersin I, Khteeb N, Katz LH, Daher S, Shamir R, Assa A. Trends in the epidemiology of inflammatory bowel disease among Jewish Israeli adolescents: a population-based study. Aliment Pharmacol Ther 2019;49:556-63. https://doi.org/10.1111/apt.15160
- Kaplan GG, Ng SC. Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology 2017;152:313-21.e2. https://doi.org/10.1053/j.gastro.2016.10.020
- Jung YS, Han M, Kim WH, Park S, Cheon JH. Incidence and clinical outcomes of inflammatory bowel disease in South Korea, 2011-2014: a nationwide population-based study. Dig Dis Sci 2017;62:2102-12. https://doi.org/10.1007/s10620-017-4640-9
- Hong SJ, Cho SM, Choe BH, Jang HJ, Choi KH, Kang B, et al. Characteristics and incidence trends for pediatric inflammatory bowel disease in Daegu-Kyungpook province in Korea: a multi-center study. J Korean Med Sci 2018;33:e132. https://doi.org/10.3346/jkms.2018.33.e132
- Lee HA, Suk JY, Choi SY, Kim ER, Kim YH, Lee CK, et al. Characteristics of pediatric inflammatory bowel disease in Korea: comparison with EUROKIDS data. Gut Liver 2015;9:756-60. https://doi.org/10.5009/gnl14338
- de Bie CI, Paerregaard A, Kolacek S, Ruemmele FM, Koletzko S, Fell JM, et al.; EUROKIDS Porto IBD Working Group of ESPGHAN. Disease phenotype at diagnosis in pediatric Crohn's disease: 5-year analyses of the EUROKIDS Registry. Inflamm Bowel Dis 2013;19:378-85. https://doi.org/10.1002/ibd.23008
- Levine A, Koletzko S, Turner D, Escher JC, Cucchiara S, de Ridder L, et al.; European Society of Pediatric Gastroenterology, Hepatology, and Nutrition. ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr 2014;58:795-806. https://doi.org/10.1097/mpg.0000000000000239
- Kim JH, Yun S, Hwang SS, Shim JO, Chae HW, Lee YJ, et al.; Committee for the Development of Growth Standards for Korean Children and Adolescents; Committee for School Health and Public Health Statistics, the Korean Pediatric Society; Division of Health and Nutrition Survey, Korea Centers for Disease Control and Prevention. The 2017 Korean National Growth Charts for children and adolescents: development, improvement, and prospects. Korean J Pediatr 2018;61:135-49. https://doi.org/10.3345/kjp.2018.61.5.135
- Levine A, Griffiths A, Markowitz J, Wilson DC, Turner D, Russell RK, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis 2011;17:1314-21. https://doi.org/10.1002/ibd.21493
- Lophaven SN, Lynge E, Burisch J. The incidence of inflammatory bowel disease in Denmark 1980-2013: a nationwide cohort study. Aliment Pharmacol Ther 2017;45:961-72. https://doi.org/10.1111/apt.13971
- Everhov AH, Olen O, Ludvigsson JF. Editorial: importance of definition of inflammatory bowel disease and an increased incidence in children. Aliment Pharmacol Ther 2017;45:1369-70. https://doi.org/10.1111/apt.14035
- Shivashankar R, Tremaine WJ, Harmsen WS, Loftus EV Jr. Incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota from 1970 through 2010. Clin Gastroenterol Hepatol 2017;15:857-63. https://doi.org/10.1016/j.cgh.2016.10.039
- Benchimol EI, Manuel DG, Guttmann A, Nguyen GC, Mojaverian N, Quach P, et al. Changing age demographics of inflammatory bowel disease in Ontario, Canada: a population-based cohort study of epidemiology trends. Inflamm Bowel Dis 2014;20:1761-9. https://doi.org/10.1097/MIB.0000000000000103
- Shah SC, Khalili H, Gower-Rousseau C, Olen O, Benchimol EI, Lynge E, et al. Sex-based differences in incidence of inflammatory bowel diseases-pooled analysis of population-based studies from Western Countries. Gastroenterology 2018;155:1079-89.e3. https://doi.org/10.1053/j.gastro.2018.06.043
- Shah SC, Khalili H, Chen CY, Ahn HS, Ng SC, Burisch J, et al. Sex-based differences in the incidence of inflammatory bowel diseases-pooled analysis of population-based studies from the Asia-Pacific region. Aliment Pharmacol Ther 2019;49:904-11. https://doi.org/10.1111/apt.15178
- Park SH, Kim YJ, Rhee KH, Kim YH, Hong SN, Kim KH, et al.; Songpa-Kangdong Inflammatory Bowel Disease [SK-IBD] Study Group. A 30-year trend analysis in the epidemiology of inflammatory bowel disease in the Songpa-Kangdong district of Seoul, Korea in 1986-2015. J Crohn's Colitis 2019;13:1410-7. https://doi.org/10.1093/ecco-jcc/jjz081
- Duricova D, Fumery M, Annese V, Lakatos PL, Peyrin-Biroulet L, Gower-Rousseau C. The natural history of Crohn's disease in children: a review of population-based studies. Eur J Gastroenterol Hepatol 2017;29:125-34. https://doi.org/10.1097/MEG.0000000000000761
- Van Limbergen J, Russell RK, Drummond HE, Aldhous MC, Round NK, Nimmo ER, et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology 2008;135:1114-22. https://doi.org/10.1053/j.gastro.2008.06.081
- Kim HJ, Oh SH, Kim DY, Lee HS, Park SH, Yang SK, et al. Clinical characteristics and long-term outcomes of paediatric Crohn's disease: a single-centre experience. J Crohn's Colitis 2017;11:157-64. https://doi.org/10.1093/ecco-jcc/jjw146
- Attard TM, Horton KM, DeVito K, Darbari A, Oliva-Hemker M, Thompson R, Cuffari C Pediatric jejunoileitis: a severe Crohn's disease phenotype that requires intensive nutritional management. Inflamm Bowel Dis 2004;10:357-60. https://doi.org/10.1097/00054725-200407000-00006
- Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002;8:244-50. https://doi.org/10.1097/00054725-200207000-00002
-
Walters TD, Kim MO, Denson LA, Griffiths AM, Dubinsky M, Markowitz J, et al.; PRO-KIIDS Research Group. Increased effectiveness of early therapy with anti-tumor necrosis factor-
${\alpha}$ vs an immunomodulator in children with Crohn's disease. Gastroenterology 2014;146:383-91. https://doi.org/10.1053/j.gastro.2013.10.027 - Kang B, Choi SY, Kim HS, Kim K, Lee YM, Choe YH. Mucosal healing in paediatric patients with moderate-to-severe luminal Crohn's disease under combined immunosuppression: escalation versus early treatment. J Crohn's Colitis 2016;10:1279-86. https://doi.org/10.1093/ecco-jcc/jjw086
- Choi J, Kang B, Kim MJ, Sohn I, Lee HJ, Choe YH. Early infliximab yields superior long-term effects on linear growth in pediatric Crohn's disease patients. Gut Liver 2018;12:255-62. https://doi.org/10.5009/gnl17290
- Bouguen G, Levesque BG, Feagan BG, Kavanaugh A, Peyrin-Biroulet L, Colombel JF, et al. Treat to target: a proposed new paradigm for the management of Crohn's disease. Clin Gastroenterol Hepatol 2015;13:1042-50.e2. https://doi.org/10.1016/j.cgh.2013.09.006
- Kang B, Choe YH. Early biologic treatment in pediatric Crohn's disease: catching the therapeutic window of opportunity in early disease by treat-to-target. Pediatr Gastroenterol Hepatol Nutr 2018;21:1-11. https://doi.org/10.5223/pghn.2018.21.1.1
- Birimberg-Schwartz L, Zucker DM, Akriv A, Cucchiara S, Cameron FL, Wilson DC, et al.; Pediatric IBD Porto group of ESPGHAN. Development and validation of diagnostic criteria for IBD subtypes including IBD-unclassified in children: a multicentre study from the Pediatric IBD Porto Group of ESPGHAN. J Crohn's Colitis 2017;11:1078-84.
- Shi HY, Levy AN, Trivedi HD, Chan FKL, Ng SC, Ananthakrishnan AN. Ethnicity influences phenotype and outcomes in inflammatory bowel disease: a systematic review and meta-analysis of population-based studies. Clin Gastroenterol Hepatol 2018;16:190-7.e11. https://doi.org/10.1016/j.cgh.2017.05.047
- Kim BJ, Song SM, Kim KM, Lee YJ, Rhee KW, Jang JY, et al. Characteristics and trends in the incidence of inflammatory bowel disease in Korean children: a single-center experience. Dig Dis Sci 2010;55:1989-95. https://doi.org/10.1007/s10620-009-0963-5
- Jin WS, Park JH, Lim KI, Tchah H, Ryoo E. Significance of perianal lesion in pediatric crohn disease. Pediatr Gastroenterol Hepatol Nutr 2018;21:184-8. https://doi.org/10.5223/pghn.2018.21.3.184
- Kang B, Lee Y, Lee K, Choi YO, Choe YH. Long-term outcomes after switching to CT-P13 in pediatric-onset inflammatory bowel disease: a single-center prospective observational study. Inflamm Bowel Dis 2018;24:607-16. https://doi.org/10.1093/ibd/izx047
- Kang B, Choi SY, Choi YO, Kim MJ, Kim K, Lee JH, et al. Subtherapeutic infliximab trough levels and complete mucosal healing are associated with sustained clinical remission after infliximab cessation in paediatric-onset Crohn's disease patients treated with combined immunosuppressive therapy. J Crohn's Colitis 2018;12:644-52. https://doi.org/10.1093/ecco-jcc/jjy021
- Kang B, Choi SY, Choi YO, Lee SY, Baek SY, Sohn I, et al. Infliximab trough levels are associated with mucosal healing during maintenance treatment with infliximab in paediatric Crohn's disease. J Crohn's Colitis 2019;13:189-97. https://doi.org/10.1093/ecco-jcc/jjy155
- Assa A, Amitai M, Greer ML, Castro DA, Kuint RC, Martinez-Leon M, et al.; ImageKids Study Group. Perianal pediatric crohn disease is associated with a distinct phenotype and greater inflammatory burden. J Pediatr Gastroenterol Nutr 2017;65:293-8. https://doi.org/10.1097/MPG.0000000000001484
- Adler J, Dong S, Eder SJ, Dombkowski KJ; ImproveCareNow Pediatric IBD Learning Health System. Perianal crohn disease in a large multicenter pediatric collaborative. J Pediatr Gastroenterol Nutr 2017;64:e117-24. https://doi.org/10.1097/MPG.0000000000001447
- Short SS, Dubinsky MC, Rabizadeh S, Farrior S, Berel D, Frykman PK. Distinct phenotypes of children with perianal perforating Crohn's disease. J Pediatr Surg 2013;48:1301-5. https://doi.org/10.1016/j.jpedsurg.2013.03.027
Cited by
- Potential Utility of Therapeutic Drug Monitoring of Adalimumab in Predicting Short-Term Mucosal Healing and Histologic Remission in Pediatric Crohn's Disease Patients vol.35, pp.17, 2020, https://doi.org/10.3346/jkms.2020.35.e114
- Prevention of thiopurine-induced early leukopenia in a Korean pediatric patient with Crohn's disease who turned out to possess homozygous mutations in NUDT15 R139C vol.37, pp.4, 2020, https://doi.org/10.12701/yujm.2020.00178
- Upper gastrointestinal tract involvement is more prevalent in Korean patients with pediatric Crohn’s disease than in European patients vol.10, pp.1, 2020, https://doi.org/10.1038/s41598-020-75938-1
- Severe Disease Activity Based on the Paris Classification Is Associated with the Development of Extraintestinal Manifestations in Korean Children and Adolescents with Ulcerative Colitis vol.36, pp.44, 2020, https://doi.org/10.3346/jkms.2021.36.e278
- How Can We Do Transition Successfully from Pediatric to Adult Clinics in Inflammatory Bowel Disease? vol.77, pp.5, 2020, https://doi.org/10.4166/kjg.2021.065
- Factors Associated with the Immunogenicity of Anti-Tumor Necrosis Factor Agents in Pediatric Patients with Inflammatory Bowel Disease vol.15, pp.4, 2020, https://doi.org/10.5009/gnl20134
- Incidentally Detected Asymptomatic Perianal Abscess in an Adolescent during Crohn's Disease Diagnosis: Is Routine Pelvic Imaging Required in Korean Pediatric Patients at Diagnosis? vol.24, pp.6, 2020, https://doi.org/10.5223/pghn.2021.24.6.564